How Obesity Influences Psoriatic Arthritis Risk and Outcomes
Living RheumHow Obesity Influences Psoriatic Arthritis Risk and Outcomes
Philip Mease, MD, MACR
Familial Chylomicronemia Syndrome: Improving Recognition and Diagnosis
On the Frontlines of Familial Chylomicronemia SyndromeFamilial Chylomicronemia Syndrome: Improving Recognition and Diagnosis
Steve Jackson, PharmD
Nivedita Patni, MD
Hypertension in Women: Cardiovascular Risk Across the Lifespan
Heart MattersHypertension in Women: Cardiovascular Risk Across the Lifespan
Shelina Ramnarine, PhD
Payal Kohli, MD, FACC
Understanding the Biology and Burden of Postpartum Depression
Advances in Women's HealthUnderstanding the Biology and Burden of Postpartum Depression
Jennifer L. Payne, MD
Conference Coverage at ICCBH 2026: A New Frontier in Achondroplasia—Clinical Insights From the PROPEL 3 Trial of Oral Infigratinib in Children
EndocrinologyConference Coverage at ICCBH 2026: A New Frontier in Achondroplasia—Clinical Insights From the PROPEL 3 Trial of Oral Infigratinib in Children
Ravi Savarirayan, MBBS, MD
Survodutide in Obesity: Insights from SYNCHRONIZE-1
Diabetes DiscourseSurvodutide in Obesity: Insights from SYNCHRONIZE-1
Carel le Roux, MBChB, MSC, FRCP, FRCPath, PhD
- advertisement
- 3 questions
- advertisement
Albuminuria: An Overlooked Red Flag in Cardiovascular Risk
Conversations in CV Risk AssessmentAlbuminuria: An Overlooked Red Flag in Cardiovascular Risk
Matthew Sorrentino, MD
Ashish Verma, MBBS
Hidden High Risk: When BP Control Isn’t Enough in Hypertension
Conversations in CV Risk AssessmentHidden High Risk: When BP Control Isn’t Enough in Hypertension
Gates B. Colbert, MD
Michael E. Hall, MD
Clyde W. Yancy, MD
Rethinking Diabetes Care: Key Data from Incorporating Lifestyle Modifications
Medical Industry FeatureRethinking Diabetes Care: Key Data from Incorporating Lifestyle Modifications
Charles Turck, PharmD, BCPS, BCCCP
Jamy Ard, MD
Michelle I. Cardel, PhD, MS, RD
- 08/06/2026
- 08/04/2026
- 07/31/2026
- 07/30/2026
- 07/29/2026
- 07/27/2026